Clinical trials: Uveitic Macular Edema
Uveitic Macular Edema
Vamikibart in Participants With Uveitic Macular Edema
This study will assess the efficacy and safety of vamikibart in participants with uveitic macular edema.
- Trial name
- Sandcat (NCT05642325)
- Testing
- Vamikibart
- Where
- 94 sites in United States, Argentina and 17 more
- Volunteers
- 256 people
- Sponsor
- Hoffmann-La Roche
Uveitic Macular Edema
A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema
This study will assess the efficacy and safety of vamikibart in participants with uveitic macular edema.
- Trial name
- Meerkat (NCT05642312)
- Testing
- Vamikibart
- Where
- 77 sites in United States, Austria and 12 more
- Volunteers
- 245 people
- Sponsor
- Hoffmann-La Roche
Diabetic Macular Edema, Uveitic Macular Edema
A Study to Investigate RO7200220 as Monotherapy and in Combination With Ranibizumab in Participants With Diabetic and Uveitic Macular Edema
The purpose of this study was to assess the safety and tolerability of RO7200220 as monotherapy (diabetic macular edema [DME] or uveitic macular edema [UME] population) and in combination with ranibizumab (DME population only).
- Trial name
- DOVETAIL (NCT06771271)
- Testing
- RO7200220, Ranibizumab
- Where
- 19 sites in United States
- Volunteers
- 85 people
- Sponsor
- Hoffmann-La Roche